MedTrace Logo

Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention

NCT06274411 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2026-05-13

No results posted yet for this study

Summary

The goal of this multicenter, randomized trial is to compare standby cannulated ECMO versus prophylactic ECMO in patients undergoing high-risk percutaneous coronary intervention (PCI). The main question it aims to answer is :

• If standby cannulated ECMO as compared with prophylactic ECMO will improve the outcomes in patients undergoing high-risk PCI

Conditions

  • ECMO
  • High-risk PCI

Interventions

PROCEDURE

Standby cannulated ECMO

Femoral cannulas are inserted and connected to the primed circuit. Clamps are kept on circuit, and ECMO is on standby during PCI. ECMO is initiated if needed.

PROCEDURE

Prophylactic ECMO

Prophylactic ECMO procedures are performed in the catheterization laboratory before PCI.

Sponsors & Collaborators

  • Wuhan Asia Heart Hospital

    collaborator OTHER

  • First Affiliated Hospital of Harbin Medical University

    collaborator OTHER

  • People's Hospital of Xinjiang Uygur Autonomous Region

    collaborator OTHER

  • People's Hospital of Guangxi Zhuang Autonomous Region

    collaborator OTHER

  • The First Affiliated Hospital of Lanzhou Medical University

    collaborator UNKNOWN

  • Chinese Academy of Medical Sciences, Fuwai Hospital

    collaborator OTHER

  • The Second Affiliated Hospital of Harbin Medical University

    collaborator OTHER

  • Beijing Anzhen Hospital

    lead OTHER

Principal Investigators

  • Xiaotong Hou, MD · Beijing Anzhen Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-21
Primary Completion
2026-11-01
Completion
2026-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06274411 on ClinicalTrials.gov